Tag: Post Covid-19

Mount Sinai Opens State-of-the-Art Center for Patients With Complex Conditions Including Lyme Disease and Long COVID

sarah JonasAnnouncement

The Cohen Center for Recovery From Complex Chronic Illnesses will also research new therapies for these conditions

Mount Sinai Expands Center for Post-COVID Care to Serve Patients in East Harlem and South Bronx

sarah JonasAnnouncement

$5 million grant from the Agency for Healthcare Research and Quality will enhance long COVID care for underserved minority groups, community outreach, and research

Nirmatrelvir-ritonavir not effective for reducing most post-COVID-19 conditions

sarah JonasResearch Results

A trial emulation study of veterans with COVID-19 found that the use of the antiviral nirmatrelvir–ritonavir was not effective for reducing the risk for many post-COVID-19 conditions, including cardiac, pulmonary, renal, gastrointestinal, neurologic, mental health, musculoskeletal, or endocrine symptoms. Nirmatrelvir–ritonavir was associated only with a reduced risk for combined thromboembolic events. The study is published in Annals of Internal Medicine.